Results 21 to 30 of about 787,863 (229)
Virtually free finite-normal-subgroup-free groups are strongly verbally closed
, 2018 Any virtually free group $H$ containing no non-trivial finite normal subgroup (e.g., the infinite dihedral group) is a retract of any finitely generated group containing $H$ as a verbally closed subgroup.Comment: 6 pages. V2: minor corrections.
Klyachko, Anton A. +2 more
core +1 more source
PICALM::MLLT10 translocated leukemia
FEBS Letters, EarlyView.This comprehensive review of PICALM::MLLT10 translocated acute leukemia provides an in‐depth review of the structure and function of CALM, AF10, and the fusion oncoprotein (1). The multifaceted molecular mechanisms of oncogenesis, including nucleocytoplasmic shuttling (2), epigenetic modifications (3), and disruption of endocytosis (4), are then ...
John M. Cullen +7 more
wiley +1 more source
Pseudocomplementation in (Normal) Subgroup Lattices [PDF]
Communications in Algebra, 2010 The goal of this article is to study finite groups admitting a pseudocomplemented subgroup lattice (PK-groups) or a pseudocomplemented normal subgroup lattice (PKN-groups). In particular, we obtain a complete classification of finite PK-groups and of finite nilpotent PKN-groups. We also study groups with a Stone normal subgroup lattice, and we classify
De Medts, Tom, Tărnăuceanu, Marius
openaire +2 more sources
Some Characterizations of a Normal Subgroup of a Group [PDF]
, 2012 Let G be a group and H be a subgroup of G which is either finite or of finite index in G. In this note, we give some characterizations for normality of H in G.
Kakkar, Vipul, Shukla, R. P.
core
Molecular Oncology, EarlyView.Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Normal subgroups contained in the Frattini subgroup. II [PDF]
Proceedings of the American Mathematical Society, 1975 If p p is an odd prime and H H is a p p -group with a characteristic subgroup K K such that | K | > | K ∩ Z ( H ) | = p
openaire +2 more sources
Normal Subsystems of Fusion Systems
, 2010 In this article we prove that for any saturated fusion system, that the (unique) smallest weakly normal subsystem of it on a given strongly closed subgroup is actually normal.
~Craven, David A.
core +1 more source
Next‐generation proteomics improves lung cancer risk prediction
Molecular Oncology, EarlyView.This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Molecular Oncology, EarlyView.Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source